Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425757
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-09
Brief Title:
Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
Sponsor:
Xie Kangjie
Organization:
Zhejiang Cancer Hospital
Study Overview
Official Title:
Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Blood concentrations of Ciprofol were measured at different time points after single injection in patients with hypoproteinemia
Detailed Description:
This study was a single-center interventional clinical study Patients with different plasma albumin levels were selected before surgery and induced by a single injection of Ciprofol at a depth of 03 mgkg 2ml of venous blood was collected before and 05 1 2 3 5 8 15 30min 1h 2h and 4h after administration The pharmacokinetics of Ciprofol were studied by measuring the concentration of Ciprofol in blood
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None